| 영문 | receptor | 한글 | 수용체 |
|---|---|---|---|
| 설명 | 세포질내 또는 세포표면에 존재하는 분자구조로서 특이물질과 선택적으로 결합하며 결합에 의해 특이한 생리적 작용을 나타낸다. 펩티드호르몬, 신경전달물질, 항원, 보체, 면역글로불린에 대한 세포표면 수용체와 스테로이드에 대한 세포질내 수용체가 있다. |
||
| ER | efficiency ratio; epigastric region; ejection rate; electroresection; emergency room; endoplasmic re... |
|---|---|
| RAR | rapidly adapting receptor; rat insulin receptor; retinoic acid receptor; right arm reclining; right ... |
| EFF | electromagnetic field focusing |
| EM | early memory; ejection murmur; electromagnetic; electron micrograph; electron microscopy, electron m... |
| EMC | electromagnetic compatibility; electron microscopy; emergency medical care; emergency medical coordi... |
| EM | Electromagnetic |
|---|---|
| EMA | Electromagnetic Articulography |
| EMF | Electromagnetic Field |
| LORETA | Low Resolution Electromagnetic Tomography |
| PEMF | Pulsing Electromagnetic Field |
| electromagnetic | <physics> Of, Pertaining to, or produced by, magnetism which is developed by the passage of an electric current. Electromagnetic engine, an engine in which the motive force is electromagnetism. Electromagnetic theory of light, a theory of light which makes it consist in the rapid alternation of transient electric currents moving transversely to the direction of the ray. (03 Mar 1998) |
|---|---|
| electromagnetic coupling | <physics> A means of extracting energy from a magnetically confined plasma, where the plasma expands and pushes on the confining magnetic field, causing electrical energy to be generated in the external field-generating circuits. (09 Oct 1997) |
| electromagnetic fields | Fields representing the joint interplay of electric and magnetic forces. (12 Dec 1998) |
| electromagnetic flowmeter | A flowmeter in which a magnetic field is applied to a blood vessel to measure flow in terms of the voltage developed by the blood as a conductor moving through the magnetic field. (05 Mar 2000) |
| electromagnetic force | <physics> One of the fundamental forces of interaction which influences charged entities. In quantum field theory, the electromagnetic force is mediated by particles of exchange called (virtual) photons. Photons are massless and travel at the speed of light c. The electromagnetic force obeys an inverse square law, which makes sense because it is mediated by particles that have an infinite lifetime (special-relativistically, time stops in a frame moving at c when observed from a non-moving frame). (05 Jan 1998) |
| electromagnetic induction | Electromagnetic waves propagated by induction in an electromagnetic field. (05 Mar 2000) |
| electromagnetic lens | <apparatus> An electromagnet designed to produce a suitably shaped magnetic field for the focusing and deflection of electrons or other charged particles in electron optical instruments (cf. Electrostatic lens.) See: microscope, electron. (05 Aug 1998) |
| electromagnetic radiation | <physics> Radiation (such as radio waves, microwaves, infrared, visible light, ultraviolet, X-rays, and gamma rays) which consists of associated, interacting electric and magnetic field waves which travel at the speed of light. All forms of electromagnetic radiation can be transmitted through vacuum. Electromagnetic waves in plasmas are generally more complex in their behaviour, depending on their frequency. (09 Oct 1997) |
| electromagnetic unit | The unit in an absolute system (CGS) of unit's utilizing the magnetic effects of current; e.g., abampere, abfarad, abhenry, abohm, abvolt. (05 Mar 2000) |
| electromagnetic wave | <physics> A wave of electric and magnetic fields that can move through space. Particles which make up the waves are called photons. (09 Oct 1997) |
| acetylcholine receptor antibodies | <neurology, investigation> A test used to measure the amount of antibodies to acetylcholine receptors on nerve endings. This is a diagnostic test for myasthenia gravis. A normal value is no antibodies in the bloodstream. Acetylcholine receptor (AChR) binding autoantibodies (i.e. Antibodies reactive with several epitopes other than the binding site for acetylcholine or alpha-bungarotoxin) are present in approximately 88% of patients with generalised myasthenia gravis, 70% of ocular myasthenia and in approximately 80% of myasthenia gravis in remission. Although serum concentrations of AChR binding autoantibodies do not in general correlate well with severity of weakness, there is typical decrease in concentration as weakness improves with immunosuppressive therapy. AChR blocking autoantibodies (i.e., antibodies reactive with the AChR binding site) are present in about 50% of patients with myasthenia gravis, 30% with ocular myasthenia gravis and 20% of myasthenia gravis in remission, AChR blocking autoantibodies are the only AChR autoantibodies present in about 1% of myasthenia gravis. AChR modulating autoantibodies (i.e., autoantibodies which cross-link AChRs and cause their removal from muscle membrane surfaces) are present in more than 90% of myasthenia gravis and occasionally are the only AchR autoantibodies detectable in mild, recent onset or ocular-restricted myasthenia gravis. Results for AChR modulating autoantibodies can be transiently false-positive due to curare-like drugs used during general anesthesia. AChR autoantibodies of one or more types are found in at least 80% of ocular myasthenia gravis. Although generally absent in neurological conditions other than myasthenia gravis(and consequently unlikely to cause confusion in neurodiagnosis), false-positive results for AChR autoantibodies occasionally occur in primary biliary cirrhosis, tardive dyskinesia, autoimmune thyroiditis, the elderly, amyotrophic lateral sclerosis patients treated with cobra venom and patients with thymoma in the absence of myasthenia gravis. Approximately 1% of patients with rheumatoid arthritis treated with D-penicillamine develop AChR autoantibodies and myasthenia gravis, both of which disappear when the drug is discontinued. Babies born to ~10% of myasthenia gravis mothers have a transient neonatal form of myasthenia gravis that responds well to anticholinesterase therapy and usually remits within 1 month as maternal IgG disappears. (29 Dec 1997) |
| amino acid receptor | <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor. (18 Nov 1997) |
| AMPA receptor | <cell biology> Glutamate operated ion channel. See: excitatory amino acid receptor channels. (05 Feb 1998) |
| ANP receptor | <molecular biology> Family of 3 receptors for atrial natriuretic peptide. ANP A and ANP B have intracellular guanylate cyclase and protein kinase like domains. ANP C, shares the extracellular ligand binding and transmembrane domains, but lacks the functional intracellular domains and is not thought to be involved in signal transduction. (18 Nov 1997) |
| asialoglycoprotein receptor | A surface receptor found in hepatocytes that binds galactose-terminal glycoproteins; thus, this receptor removes those proteins from circulation and they are in turn acted upon by hepatocyte lysosomes. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|